Ambu A/S (CPH:AMBU.B)
Denmark · Delayed Price · Currency is DKK 96.80
+0.50 (0.52%)
Sep 2, 2025, 1:19 PM CET
Ambu A/S Market Cap
Ambu A/S has a market cap or net worth of 25.65 billion as of September 2, 2025. Its market cap has decreased by -32.71% in one year.
Market Cap
25.65B
Enterprise Value
25.44B
Revenue
5.96B
Ranking
n/a
PE Ratio
71.77
Stock Price
96.80
Market Cap Chart
Since August 8, 1994, Ambu A/S's market cap has increased from 290.04M to 25.65B, an increase of 8,744.81%. That is a compound annual growth rate of 15.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2025 | 25.65B | -7.40% |
| Dec 30, 2024 | 27.70B | -1.11% |
| Dec 29, 2023 | 28.01B | 23.89% |
| Dec 30, 2022 | 22.61B | -48.49% |
| Dec 30, 2021 | 43.90B | -32.73% |
| Dec 30, 2020 | 65.26B | 138.06% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,594.30B |
| Coloplast | 137.98B |
| Genmab | 97.67B |
| Demant | 51.98B |
| ALK-Abelló | 44.50B |
| H. Lundbeck | 38.60B |
| Zealand Pharma | 30.78B |
| Bavarian Nordic | 18.42B |